Virtual Reality for Sickle Cell Disease
Trial Summary
What is the purpose of this trial?
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using virtual reality alongside standard care, so you may not need to stop your medications, but it's best to confirm with the trial organizers.
What data supports the effectiveness of the treatment Virtual Reality Devices, VR Therapy, Virtual Reality Technology, Immersive VR for Sickle Cell Disease?
How does virtual reality treatment differ from other treatments for sickle cell disease?
Virtual reality (VR) treatment for sickle cell disease is unique because it uses immersive technology to help manage pain during vaso-occlusive episodes, which are painful events common in this condition. Unlike traditional pain management methods that rely on medication, VR offers a non-drug approach by providing a distraction and potentially reducing the perception of pain.13567
Research Team
R. Gentry Wilklerson, MD
Principal Investigator
U of Maryland, Baltimore
Eligibility Criteria
This trial is for patients with sickle cell disease who are currently experiencing a vaso-occlusive crisis. It's designed to see if virtual reality can help manage their pain alongside the usual treatments they receive.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use virtual reality devices or placebo for a maximum of 2 hours during a single session in the emergency department
Follow-up
Participants are monitored for changes in pain scores and other outcomes immediately after the intervention and 1 hour post-intervention
Treatment Details
Interventions
- Virtual Reality Devices
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor